PGD2
Pgd2 is a lipid of Fatty Acyls (FA) class. Pgd2 is associated with abnormalities such as Inflammatory disorder, Pleurisy, Rhinitis, Dehydration and Pneumonia. The involved functions are known as antagonists, fat cell differentiation, Phosphorylation, Process and Gene Expression. Pgd2 often locates in Cell surface, Body tissue, Extracellular, Bone Marrow and Membrane. The associated genes with PGD2 are oxytocin, 1-desamino-(O-Et-Tyr)(2)-, P4HTM gene, PTGS2 gene, PTGDS gene and IL3 gene. The related lipids are 15-deoxyprostaglandin J2, Nonesterified Fatty Acids, Lipopolysaccharides, Steroids and Liposomes. The related experimental models are Knock-out and Rodent Model.
Cross Reference
Introduction
To understand associated biological information of PGD2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with PGD2?
PGD2 is suspected in Asthma, Dehydration, Allergic rhinitis NOS, Rhinitis, Infertility, Pneumonia and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with PGD2
PubChem Associated disorders and diseases
What pathways are associated with PGD2
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with PGD2?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with PGD2?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with PGD2?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with PGD2?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with PGD2?
Knock-out
Knock-out are used in the study 'Multiple roles of the prostaglandin D2 signaling pathway in reproduction.' (Rossitto M et al., 2015).
Rodent Model
Rodent Model are used in the study 'PKA regulatory IIα subunit is essential for PGD2-mediated resolution of inflammation.' (Kong D et al., 2016).
Related references are published most in these journals:
| Model | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
NCBI Entrez Crosslinks
All references with PGD2
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Abraki SB et al. | Simultaneous inhibition of COX-2 and activation of PPAR-γ resulted in the same level and pattern of neuroprotection as they were targeted separately. | 2013 | J. Mol. Neurosci. | pmid:23132402 |
| Fiebich BL et al. | Potential link between interleukin-6 and arachidonic acid metabolism in Alzheimer's disease. | 1998 | J. Neural Transm. Suppl. | pmid:9850935 |
| Kitanaka J et al. | Phloretin as an antagonist of prostaglandin F2 alpha receptor in cultured rat astrocytes. | 1993 | J. Neurochem. | pmid:8093482 |
| Haskew-Layton RE et al. | 15-Deoxy-Δ12,14-prostaglandin J2 (15d-PGJ2) protects neurons from oxidative death via an Nrf2 astrocyte-specific mechanism independent of PPARγ. | 2013 | J. Neurochem. | pmid:23199167 |
| Hosoi T et al. | Possible involvement of 15-deoxy-Δ(12,14) -prostaglandin J2 in the development of leptin resistance. | 2015 | J. Neurochem. | pmid:25662180 |
| Satoh T et al. | Neurotrophic actions of novel compounds designed from cyclopentenone prostaglandins. | 2001 | J. Neurochem. | pmid:11279261 |
| Fiebich BL et al. | Prostaglandin E2 induces interleukin-6 synthesis in human astrocytoma cells. | 1997 | J. Neurochem. | pmid:9003059 |
| Fujimori K et al. | Prevention of paraquat-induced apoptosis in human neuronal SH-SY5Y cells by lipocalin-type prostaglandin D synthase. | 2012 | J. Neurochem. | pmid:22043816 |
| Zander T et al. | Induction of apoptosis in human and rat glioma by agonists of the nuclear receptor PPARgamma. | 2002 | J. Neurochem. | pmid:12065618 |
| Yagami T et al. | Group IB secretory phospholipase A2 induces neuronal cell death via apoptosis. | 2002 | J. Neurochem. | pmid:12065654 |
| Vesin MF et al. | Preferential synthesis of prostaglandin D2 by neurons and prostaglandin E2 by fibroblasts and nonneuronal cells in chick dorsal root ganglia. | 1991 | J. Neurochem. | pmid:2051162 |
| Hatanaka M et al. | Late-phase accumulation of inositol phosphates stimulated by prostaglandins D2 and F2 alpha in neuroblastoma x glioma hybrid NG108-15 cells. | 1989 | J. Neurochem. | pmid:2507741 |
| Liang X et al. | Prostaglandin D2 mediates neuronal protection via the DP1 receptor. | 2005 | J. Neurochem. | pmid:15659218 |
| Huang W et al. | PPARalpha and PPARgamma effectively protect against HIV-induced inflammatory responses in brain endothelial cells. | 2008 | J. Neurochem. | pmid:18710415 |
| Ajmone-Cat MA et al. | Prolonged exposure of microglia to lipopolysaccharide modifies the intracellular signaling pathways and selectively promotes prostaglandin E2 synthesis. | 2003 | J. Neurochem. | pmid:14622099 |
| Phulwani NK et al. | 15-deoxy-Delta12,14-prostaglandin J2 (15d-PGJ2) and ciglitazone modulate Staphylococcus aureus-dependent astrocyte activation primarily through a PPAR-gamma-independent pathway. | 2006 | J. Neurochem. | pmid:17074064 |
| Oda A et al. | Characterization of ovolin, an orally active tryptic peptide released from ovalbumin with anxiolytic-like activity. | 2012 | J. Neurochem. | pmid:22564055 |
| Grill M et al. | Effect of endotoxin treatment on the expression and localization of spinal cyclooxygenase, prostaglandin synthases, and PGD2 receptors. | 2008 | J. Neurochem. | pmid:18028337 |
| Terao A et al. | Roles of prostaglandins D2 and E2 in interleukin-1-induced activation of norepinephrine turnover in the brain and peripheral organs of rats. | 1995 | J. Neurochem. | pmid:7595573 |
| Arnaud LT et al. | Proteasome-caspase-cathepsin sequence leading to tau pathology induced by prostaglandin J2 in neuronal cells. | 2009 | J. Neurochem. | pmid:19457109 |
| Bernardo A et al. | 15-deoxy-delta12,14-prostaglandin J2 regulates the functional state and the survival of microglial cells through multiple molecular mechanisms. | 2003 | J. Neurochem. | pmid:14535956 |
| Kielian T et al. | S. aureus-dependent microglial activation is selectively attenuated by the cyclopentenone prostaglandin 15-deoxy-Delta12,14- prostaglandin J2 (15d-PGJ2). | 2004 | J. Neurochem. | pmid:15312171 |
| Vesin MF and Droz B | Biosynthesis of prostaglandins D2 and E2 in chick dorsal root ganglion during development. | 1991 | J. Neurochem. | pmid:1904909 |
| Wolfe LS et al. | Metabolism of prostaglandin D2 by human cerebral cortex into 9 alpha, 11 beta-prostaglandin F2 by an active NADPH-dependent 11-ketoreductase. | 1989 | J. Neurochem. | pmid:2723663 |
| Saito Y et al. | Protective effects of 15-deoxy-Delta12,14-prostaglandin J2 against glutamate-induced cell death in primary cortical neuron cultures: induction of adaptive response and enhancement of cell tolerance primarily through up-regulation of cellular glutathione. | 2007 | J. Neurochem. | pmid:17697048 |
| Terao A et al. | Gene expression in the rat brain during prostaglandin D2 and adenosinergically-induced sleep. | 2008 | J. Neurochem. | pmid:18331290 |
| Gebicke-Haerter PJ et al. | Regulation and glucocorticoid-independent induction of lipocortin I in cultured astrocytes. | 1991 | J. Neurochem. | pmid:1828830 |
| Ogorochi T et al. | Regional distribution of prostaglandins D2, E2, and F2 alpha and related enzymes in postmortem human brain. | 1984 | J. Neurochem. | pmid:6427411 |
| Ueno R et al. | Changes of enzymes involved in prostaglandin metabolism and prostaglandin binding proteins in rat brain during development and aging. | 1985 | J. Neurochem. | pmid:3925085 |
| Marriott DR et al. | Substance P-induced release of prostaglandins from astrocytes: regional specialisation and correlation with phosphoinositol metabolism. | 1991 | J. Neurochem. | pmid:1702831 |
| Miwa N et al. | Prostaglandin induces Ca2+ influx and cyclic GMP formation in mouse neuroblastoma X rat glioma hybrid NG108-15 cells in culture. | 1988 | J. Neurochem. | pmid:2834513 |
| Sutarmo Setiadji V et al. | Actions of prostaglandin E2 on rat supraoptic neurones. | 1998 | J. Neuroendocrinol. | pmid:9870750 |
| Storer PD et al. | Peroxisome proliferator-activated receptor-gamma agonists inhibit the activation of microglia and astrocytes: implications for multiple sclerosis. | 2005 | J. Neuroimmunol. | pmid:15748950 |
| Takayama F et al. | Possible involvement of aiPLA2 in the phosphatidylserine-containing liposomes induced production of PGE2 and PGD2 in microglia. | 2013 | J. Neuroimmunol. | pmid:23850486 |
| Zhang F et al. | Peroxisome proliferator-activated receptor-gamma agonists suppress iNOS expression induced by LPS in rat primary Schwann cells. | 2010 | J. Neuroimmunol. | pmid:19942298 |
| Drew PD and Chavis JA | The cyclopentone prostaglandin 15-deoxy-Delta(12,14) prostaglandin J2 represses nitric oxide, TNF-alpha, and IL-12 production by microglial cells. | 2001 | J. Neuroimmunol. | pmid:11282151 |
| Waits PS et al. | Nociceptin/orphanin FQ modulates human T cell function in vitro. | 2004 | J. Neuroimmunol. | pmid:15020071 |
| Diab A et al. | Ligands for the peroxisome proliferator-activated receptor-gamma and the retinoid X receptor exert additive anti-inflammatory effects on experimental autoimmune encephalomyelitis. | 2004 | J. Neuroimmunol. | pmid:14975592 |
| Yuhas Y et al. | Involvement of prostaglandins in an animal model of Shigella-related seizures. | 2005 | J. Neuroimmunol. | pmid:16139898 |
| Garg TK and Chang JY | Methylmercury causes oxidative stress and cytotoxicity in microglia: attenuation by 15-deoxy-delta 12, 14-prostaglandin J2. | 2006 | J. Neuroimmunol. | pmid:16225932 |
| Heneka MT et al. | Peroxisome proliferator-activated receptor gamma agonists protect cerebellar granule cells from cytokine-induced apoptotic cell death by inhibition of inducible nitric oxide synthase. | 1999 | J. Neuroimmunol. | pmid:10695726 |
| Froldi M et al. | Mediator release in cerebrospinal fluid of human immunodeficiency virus-positive patients with central nervous system involvement. | 1992 | J. Neuroimmunol. | pmid:1315794 |
| Raikwar HP et al. | PPARgamma antagonists reverse the inhibition of neural antigen-specific Th1 response and experimental allergic encephalomyelitis by Ciglitazone and 15-deoxy-Delta12,14-prostaglandin J2. | 2006 | J. Neuroimmunol. | pmid:16844232 |
| Zhao ML et al. | 15-deoxy-delta (12,14)-PGJ2 inhibits astrocyte IL-1 signaling: inhibition of NF-kappaB and MAP kinase pathways and suppression of cytokine and chemokine expression. | 2004 | J. Neuroimmunol. | pmid:15265671 |
| Rodriguez y Baena R et al. | A study on cisternal CSF levels of arachidonic acid metabolites after aneurysmal subarachnoid hemorrhage. | 1988 | J. Neurol. Sci. | pmid:3132538 |
| De Nuccio C et al. | Peroxisome proliferator-activated receptor γ agonists accelerate oligodendrocyte maturation and influence mitochondrial functions and oscillatory Ca(2+) waves. | 2011 | J. Neuropathol. Exp. Neurol. | pmid:21937914 |
| Bernardo A et al. | Peroxisome proliferator-activated receptor-gamma agonists promote differentiation and antioxidant defenses of oligodendrocyte progenitor cells. | 2009 | J. Neuropathol. Exp. Neurol. | pmid:19535992 |
| Tan W et al. | Modulation of nicotinic AChR channels by prostaglandin E2 in chick sympathetic ganglion neurons. | 1998 | J. Neurophysiol. | pmid:9463448 |
| Mohri I et al. | Prostaglandin D2-mediated microglia/astrocyte interaction enhances astrogliosis and demyelination in twitcher. | 2006 | J. Neurosci. | pmid:16624958 |
| Heneka MT et al. | Peroxisome proliferator-activated receptor-gamma ligands reduce neuronal inducible nitric oxide synthase expression and cell death in vivo. | 2000 | J. Neurosci. | pmid:10995830 |
| Lee B et al. | Prostaglandin D synthase in the prenatal ovine brain and effects of its inhibition with selenium chloride on fetal sleep/wake activity in utero. | 2002 | J. Neurosci. | pmid:12097519 |
| Taniguchi H et al. | Prostaglandin D2 protects neonatal mouse brain from hypoxic ischemic injury. | 2007 | J. Neurosci. | pmid:17442814 |
| Terao A et al. | Interleukin-1 induces slow-wave sleep at the prostaglandin D2-sensitive sleep-promoting zone in the rat brain. | 1998 | J. Neurosci. | pmid:9698346 |
| Mouihate A et al. | A novel antipyretic action of 15-deoxy-Delta12,14-prostaglandin J2 in the rat brain. | 2004 | J. Neurosci. | pmid:14960602 |
| Chattopadhyay N et al. | Expression of peroxisome proliferator-activated receptors (PPARS) in human astrocytic cells: PPARgamma agonists as inducers of apoptosis. | 2000 | J. Neurosci. Res. | pmid:10861801 |
| Li Z et al. | Neurotoxic prostaglandin J2 enhances cyclooxygenase-2 expression in neuronal cells through the p38MAPK pathway: a death wish? | 2004 | J. Neurosci. Res. | pmid:15523637 |
| Storer PD et al. | Cyclopentenone prostaglandins PGA2 and 15-deoxy-delta12,14 PGJ2 suppress activation of murine microglia and astrocytes: implications for multiple sclerosis. | 2005 | J. Neurosci. Res. | pmid:15723383 |
| Smith SA et al. | Effects of peroxisome proliferator-activated receptor gamma ligands ciglitazone and 15-deoxy-delta 12,14-prostaglandin J2 on rat cultured cerebellar granule neuronal viability. | 2003 | J. Neurosci. Res. | pmid:12774315 |
| Alvarez-Dolado M et al. | Retinoic acid and 1,25-dihydroxyvitamin D3 inhibit tenascin-C expression in rat glioma C6 cells. | 1999 | J. Neurosci. Res. | pmid:10502285 |
| Kim SE et al. | 15-deoxy-Δ¹²,¹ⴠ-prostaglandin J₂ inhibits human immunodeficiency virus-1 tat-induced monocyte chemoattractant protein-1/CCL2 production by blocking the extracellular signal-regulated kinase-1/2 signaling pathway independently of peroxisome proliferator-activated receptor-γ and heme oxygenase-1 in rat hippocampal slices. | 2012 | J. Neurosci. Res. | pmid:22487967 |
| Lysz TW et al. | Measurement of prostaglandin biosynthetic capacity in discrete areas of the rabbit hippocampal formation. | 1983 | J. Neurosci. Res. | pmid:6580469 |
| Nakagomi T et al. | Effect of removal of the endothelium on vasocontraction in canine and rabbit basilar arteries. | 1988 | J. Neurosurg. | pmid:2895803 |
| Rodriguez y Baena R et al. | Effects of nicardipine on the ex vivo release of eicosanoids after experimental subarachnoid hemorrhage. | 1989 | J. Neurosurg. | pmid:2585083 |
| Zanoni G et al. | First enantioselective total synthesis of (8S,12R,15S)-prostaglandin J(2). | 2003 | J. Org. Chem. | pmid:12895084 |
| Zanoni G et al. | A --> J prostaglandin swap: a new tactic for cyclopentenone prostaglandin synthesis. | 2003 | J. Org. Chem. | pmid:12919053 |
| Zanoni G et al. | First total synthesis of JS isoprostane. | 2003 | J. Org. Chem. | pmid:12868940 |
| Kim NJ et al. | Concise and enantioselective total synthesis of 15-deoxy-Δ-(12,14)-prostaglandin J(2). | 2010 | J. Org. Chem. | pmid:20929274 |
| Patel P et al. | Enantio- and stereospecific syntheses of 15(R)-Me-PGD2, a potent and selective DP2-receptor agonist. | 2008 | J. Org. Chem. | pmid:18700746 |
| Gao T et al. | Arachidonic acid metabolism to prostaglandin E2, D2, F2alpha, and I2 in the plerocercoid of Spirometra erinaceieuropaei. | 1998 | J. Parasitol. | pmid:9920298 |
| Mirza RE et al. | Macrophage PPARγ and impaired wound healing in type 2 diabetes. | 2015 | J. Pathol. | pmid:25875529 |
| Hokari R et al. | Increased expression and cellular localization of lipocalin-type prostaglandin D synthase in Helicobacter pylori-induced gastritis. | 2009 | J. Pathol. | pmid:19768745 |
| Soifer SJ et al. | Effects of prostaglandin D2 on pulmonary arterial pressure and oxygenation in newborn infants with persistent pulmonary hypertension. | 1988 | J. Pediatr. | pmid:3162978 |
| Ford WD et al. | Pulmonary hypertension in lambs with congenital diaphragmatic hernia: vasodilator prostaglandins, isoprenaline, and tolazoline. | 1990 | J. Pediatr. Surg. | pmid:2352080 |
| Siddhivarn C et al. | Mechanical loading and delta12prostaglandin J2 induce bone morphogenetic protein-2, peroxisome proliferator-activated receptor gamma-1, and bone nodule formation in an osteoblastic cell line. | 2007 | J. Periodont. Res. | pmid:17760815 |
| Siddhivarn C et al. | Prostaglandin D2 pathway and peroxisome proliferator-activated receptor gamma-1 expression are induced by mechanical loading in an osteoblastic cell line. | 2006 | J. Periodont. Res. | pmid:16499711 |
| Mendieta CF et al. | Biosynthesis of prostaglandins in gingiva of patients with chronic periodontitis. | 1985 | J. Periodontol. | pmid:3919173 |
| Ko FN et al. | Mechanism of action of p-chlorobiphenyl on the inhibition of platelet aggregation. | 1996 | J. Pharm. Pharmacol. | pmid:8794990 |
| Bhattacharya SK et al. | Effect of centrally administered prostaglandin D2 and some prostaglandin synthesis inhibitors on carrageenan-induced paw oedema in rats. | 1989 | J. Pharm. Pharmacol. | pmid:2571705 |
| Sharif NA and Davis TL | Cloned human EP1 prostanoid receptor pharmacology characterized using radioligand binding techniques. | 2002 | J. Pharm. Pharmacol. | pmid:11999132 |
| Gambero A and Gomes JC | Pharmacological antagonism of Anchietia salutaris extracts on the contraction induced by prostaglandin D2 and U46619 in guinea-pig lung parenchymal strips. | 1998 | J. Pharm. Pharmacol. | pmid:9877316 |
| Guh JH et al. | Antiplatelet effect of gingerol isolated from Zingiber officinale. | 1995 | J. Pharm. Pharmacol. | pmid:7791032 |
| Bhattacharya SK and Parmar SS | Prostaglandin D2-induced potentiation of hexobarbitone hypnosis in rats: role of 5-hydroxytryptamine. | 1985 | J. Pharm. Pharmacol. | pmid:2868104 |
| Bhattacharya SK and Rao PJ | Prostaglandin D2-induced catalepsy in rats: role of 5-hydroxytryptamine. | 1987 | J. Pharm. Pharmacol. | pmid:2890744 |
| Nagira Y et al. | Prostaglandin D2 Modulates Neuronal Excitation of the Trigeminal Ganglion to Augment Allergic Rhinitis in Guinea Pigs. | 2016 | J. Pharmacol. Exp. Ther. | pmid:26945085 |
| Almishri W et al. | Effects of prostaglandin D2, 15-deoxy-Delta12,14-prostaglandin J2, and selective DP1 and DP2 receptor agonists on pulmonary infiltration of eosinophils in Brown Norway rats. | 2005 | J. Pharmacol. Exp. Ther. | pmid:15590767 |
| Sharif NA et al. | Affinities, selectivities, potencies, and intrinsic activities of natural and synthetic prostanoids using endogenous receptors: focus on DP class prostanoids. | 2000 | J. Pharmacol. Exp. Ther. | pmid:10772998 |
| Pettipher R et al. | Pharmacologic profile of OC000459, a potent, selective, and orally active D prostanoid receptor 2 antagonist that inhibits mast cell-dependent activation of T helper 2 lymphocytes and eosinophils. | 2012 | J. Pharmacol. Exp. Ther. | pmid:22106101 |
| Peters SP et al. | Mediator release from human lung under conditions of reduced oxygen tension. | 1986 | J. Pharmacol. Exp. Ther. | pmid:2425080 |
| Lacal PM et al. | Effects of cyclopentenone prostaglandins on myeloid cells during early infection with HTLV-I. I. Cell differentiation determines sensitivity to prostaglandins and virus infection. | 1994 | J. Pharmacol. Exp. Ther. | pmid:7965770 |
| Lacal PM et al. | Effects of cyclopentenone prostaglandins on myeloid cells during early infection with HTLV-I. II. Regulation of synthesis of inducible p72 heat shock protein. | 1994 | J. Pharmacol. Exp. Ther. | pmid:7965771 |
| Kriseman T et al. | Analysis of airway responses to A23187 in the cat. | 1986 | J. Pharmacol. Exp. Ther. | pmid:3095538 |
| Monneret G et al. | Effects of prostaglandin D(2) and 5-lipoxygenase products on the expression of CD203c and CD11b by basophils. | 2005 | J. Pharmacol. Exp. Ther. | pmid:15388786 |
| Tajima T et al. | Lipopolysaccharide induces macrophage migration via prostaglandin D(2) and prostaglandin E(2). | 2008 | J. Pharmacol. Exp. Ther. | pmid:18492946 |
| Weichman BM et al. | SK&F 88046: a unique pharmacologic antagonist of bronchoconstriction induced by leukotriene D4, thromboxane and prostaglandins F2 alpha and D2 in vitro. | 1984 | J. Pharmacol. Exp. Ther. | pmid:6582266 |
| Undem BJ et al. | Isoproterenol-induced inhibition of immunoglobulin E-mediated release of histamine and arachidonic acid metabolites from the human lung mast cell. | 1988 | J. Pharmacol. Exp. Ther. | pmid:2459368 |
| Kim EJ et al. | Peroxisome proliferator-activated receptor-gamma activator 15-deoxy-Delta12,14-prostaglandin J2 inhibits neuroblastoma cell growth through induction of apoptosis: association with extracellular signal-regulated kinase signal pathway. | 2003 | J. Pharmacol. Exp. Ther. | pmid:12966153 |
| Tachikawa M et al. | A clearance system for prostaglandin D2, a sleep-promoting factor, in cerebrospinal fluid: role of the blood-cerebrospinal barrier transporters. | 2012 | J. Pharmacol. Exp. Ther. | pmid:22931759 |
| Yu R et al. | Competitive enzymatic interactions determine the relative amounts of prostaglandins E2 and D2. | 2011 | J. Pharmacol. Exp. Ther. | pmid:21865441 |
| Cossette C et al. | Agonist and antagonist effects of 15R-prostaglandin (PG) D2 and 11-methylene-PGD2 on human eosinophils and basophils. | 2007 | J. Pharmacol. Exp. Ther. | pmid:17041009 |
| Raman P et al. | 15-Deoxy-Δ¹²,¹â´-prostaglandin Jâ‚‚-glycerol, a putative metabolite of 2-arachidonyl glycerol and a peroxisome proliferator-activated receptor γ ligand, modulates nuclear factor of activated T cells. | 2012 | J. Pharmacol. Exp. Ther. | pmid:22700433 |